Results 101 to 110 of about 74,875 (119)

Non-clinical similarity of biosimilar ABP 798 with rituximab reference product

Biologicals, 2021
Helen J Mcbride, Shea Jassem, Vincent Chow   +2 more
exaly  

Analytical and functional similarity of biosimilar ABP 798 with rituximab reference product

Biologicals, 2020
Neungseon Seo, Zhe Huang, Scott Kuhns
exaly  

A Randomized, Double‐Blind Study Comparing Pharmacokinetics and Pharmacodynamics of Proposed Biosimilar ABP 798 With Rituximab Reference Product in Subjects With Moderate to Severe Rheumatoid Arthritis

Clinical Pharmacology in Drug Development, 2020
Gerd R Burmester, David Chien, Vincent Chow   +2 more
exaly  

Efficacy and safety results from a randomized double-blind study comparing proposed biosimilar ABP 798 with rituximab reference product in subjects with moderate-to-severe rheumatoid arthritis

Clinical Rheumatology, 2020
Gerd R Burmester, David Chien
exaly  

Rate and concentration‐dependent effects of UK‐68,798, a potent new class III antiarrhythmic, on canine Purkinje fibre action potential duration and Vmax

British Journal of Pharmacology, 1991
Timothy K Knilans, David A Lathrop, Peter P Nanasi   +2 more
exaly  

Measurement of the class III antidysrhythmic drug, UK-68,798, in plasma by radioimmunoassay

Journal of Pharmaceutical and Biomedical Analysis, 1991
B Kaye
exaly  

Interpretation of 798: Changes in Power of Representation and Sustainability of Industrial Landscape

Sustainability, 2015
Juncheng Dai, Huasheng Zhu, Zhu Huasheng   +2 more
exaly  

Validation of five X-chromosomal STRs DXS6800, DXS6807, DXS6798, DXS8377 and DXS7423 in an Antioquian population sample

International Congress Series, 2006
J J Builes, Leonor Gusmão, M L J Bravo   +2 more
exaly  

Effects of altered extracellular potassium and pacing cycle length on the class III antiarrhythmic actions of dofetilide (UK-68,798) in guinea-pig papillary muscle

Cardiovascular Drugs and Therapy, 1992
David A Lathrop, Helge Refsum, P M Tande   +2 more
exaly  

Negative chronotropic effect of a novel class III antiarrhythmic drug, UK‐68,798, devoid of β‐blocking action on isolated guinea‐pig atria

British Journal of Pharmacology, 1991
Pal M Tande, Helge Refsum, P M Tande
exaly